Lanean...
Gastroprokinetic agent, mosapride inhibits 5-HT(3) receptor currents in NCB-20 cells
Mosapride accelerates gastric emptying by acting on 5-hydroxytryptamine type 4 (5-HT(4)) receptor and is frequently used in the treatment of gastrointestinal (GI) disorders requiring gastroprokinetic efficacy. We tested the effect of mosapride on 5-hydroxytryptamine type 3 (5-HT(3)) receptor current...
Gorde:
| Argitaratua izan da: | Korean J Physiol Pharmacol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Korean Physiological Society and The Korean Society of Pharmacology
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717790/ https://ncbi.nlm.nih.gov/pubmed/31496879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2019.23.5.419 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|